Prevalence of antinuclear envelope antibodies and their isotypes in sera positive for antinuclear antibodies;Prevalencia de anticuerpos anti envoltura nuclear y sus isotipos en sueros positivos para anticuerpos antinucleares

Medicina

Volumn 66, Issue 4, 2006, Pages 327-331

  Arcavi, Miriam ^a   Orfus, Gladys ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antinuclear antibodies; Nuclear envelope; Nuclear lamina; Nuclear pore complexes; Rim Pattern

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY; SMOOTH MUSCLE ANTIBODY;

ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HEP 2 CELL; HUMAN; HUMAN CELL; LIVER DISEASE; MAJOR CLINICAL STUDY; NONHUMAN; PRACTICE GUIDELINE; RODENT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN ISOTYPES; MODELS, ANIMAL; NUCLEAR ENVELOPE; NUCLEAR LAMINA; NUCLEAR PORE; RATS;

EID: 33748709889     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Seminars in Artritis Rheumatism 1995; 24: 323-58.
2. Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.J Autoimmune Dis 2004; 1: 2.
3. Forslid J, Heigl Z, Jonsson J, Scheynius A. The prevalence of antinuclear antibodies in healthy young persons and adults, comparing rat liver tissue sections with HEp-2 cells as antigen substrate. Clin Exp Rheumatol 1994; 12: 137-41.
4. López-Longo FJ, Rodríguez Mahon M, Grau R, Carreño L. Autoanticuerpos en las enfermedades reumáticas. Clasificación y técnicas de detección. Rev Esp Reumatol 1966; 23: 343-9.
5. Konstantinov K, Foisner R, Byrd D, et al. Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope. Clin Immunol Immunophathol 1995; 74: 89-99.
6. Konstantinov KN. Nuclear envelope protein autoantibodies. In: Peter JB, Schoenfeld Y (eds). Autoantibodies. 1st ed. Amsterdam: Elsevier Sc, 1996, p 561-6.
7. McKeon FD, Tuffanelli DL, Fukuyama K, Kirschner MW. Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci USA 1983; 80: 4374-8.
8. Nesher G, Margalit R, Ashkenazi Y.J. Anti-nuclear envelope antibodies: Clinical associations. Seminars in Arthritis Rheumatism 2001; 30: 313-20.
9. Lassoued K, Danon F, Brouet JC. Human autoantibodies to lamin B receptor are also anti-idiotypic to certain anti- lamin B antibodies. Eur J Immunol 1991; 21: 1959-62.
10. Von Mickecz A,-Konstantinov K, Buchwald DS, Gerace L, Tan EM. High frecuency of autoantibodies to insoluble celullar antigens in patients with chronic fatigue syndrome. Artritis Rheum 1097; 40: 295-305.
11. Lassoued K, Andre C, Danon F, et al. Characterization of two human monoclonal IgM antibodies that recognize nuclear lamins. Eur J Immunol 1992; 22: 1547-51.
12. Miyachi K, Hankins RW, Matsushima H, et al. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Atoimmun 2003; 20: 247-54.
13. Muratori P, Muratori L, Ferrari R, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003; 98: 431-7.
14. Bradwell AR, Hughes RG, Harden EL Atlas of HEp-2 patterns. 2nd ed. Birmingham, UK: The Binding Site, 2003, p 36-9.
15. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the anti-nuclear antibody test and test for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000; 124: 71-81.
16. Tozzoli R, Bizzaro, N, Tonutti E, et al. Guidelines for the laboratory use of autoantibody test in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Path 2002; 117: 316-324.
17. Garde JB, López Longo FJ, Herranz Hermosa JM. Autoanticuerpos en las enfermedades autoinmunes del tejido conectivo. Actas Dermosifiliogr 1999; 90: 1-7.
18. Tan EM, Feltkamp TEW, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-11.
19. Arcavi M, Orfus G, Griemberg G. Diagnosis of toxoplasmosis by joint detection of immunoglobulin A and immunoglobulin M. J Clin Microbiol 1997; 35: 1450-53.
20. Joassin L, Reginster M. Elimination of nonspecific cytomegalovirus immunoglobulin M activities in theenzyme-linked immunosorbent assay by using anti-human immunoglobulin G. J Clin Microbiol 1986; 23: 576-81.
21. Martin V, Arcavi M, Santillan G, et al. Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein. Clin Diagn Lab Immunol 1998; 5: 627-31.
22. Wanchu AA. Antinuclear antibodies: clinical applications. J Postgrad Med 2000; 46: 144-8.
23. Itoh S, Ichida T, Yoshida T, et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex asa prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1998; 13: 257-65.
24. Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis 1997; 17: 79-90.
25. Bootsma H, Spronk PE, Ter Borg EJ, Hummel EJ, de Boer G, Limburg PC, Kallenberg CG. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation. Ann Rheum Dis 1997; 56: 661-6.
26. Gompertz NR, Isenberg DA, Turner BM. Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA, and IgM isotypes. Ann Rheum Dis 1990 Jul; 49: 524-7.
27. Miltenburg AM, Roos A, Slegtenhorst L, Daha MR, Breedveld FC. IgA anti-dsDNA antibodies in systemic lupus erythematosus: occurrence, incidence and association with clinical and laboratory variables of disease activity. J Rheumatol 1993; 20: 53-8.